Back to Results
First PageMeta Content
Morphinans / Drug rehabilitation / Alcohols / Euphoriants / Drug addiction / Drug Addiction Treatment Act / Buprenorphine / Methadone / Treatment Improvement Protocols / Chemistry / Organic chemistry / Pharmacology


SAMHSA Letter to Opioid Treatment Programs
Add to Reading List

Document Date: 2013-03-08 12:19:00


Open Document

File Size: 412,53 KB

Share Result on Facebook

City

Rockville / /

Company

OTPs / SAMHSA / The American Journal / Dupont / /

Country

United States / /

Currency

USD / /

/

Event

FDA Phase / Product Recall / Product Issues / /

IndustryTerm

buprenorphine combination products / appropriate / public law / treatment products / methadone products / sterile injection equipment / law enforcement operations / biological product / food processors / on-line qualifying training / opioid drug products / insurance providers / treatment improvement protocols / buprenorphine treatment products / pain treatment products / federal law / food retailers / pharmaceuticals / buprenorphine products / certain buprenorphine pain treatment products / buprenorphine and buprenorphine combination products / buprenorphine addiction treatment products / timely product / food handlers / counseling and other services / /

MedicalCondition

intravenous drug abuse / early drug abuse / Buprenorphine Epidemic / pediatric buprenorphine poisoning / severe illness / mental illness / narcotic addiction / pain / prescription drug abuse / Opiate Addiction / infectious disease / drug seizures / /

MedicalTreatment

counseling / /

Organization

Center for Substance Abuse Treatment / Food and Drug Administration / Division of Pharmacologic Therapies / FDA REMS / Center for Substance Abuse Treatment Enclosure / office of Pesticide Programs / American Association of Poison Control Centers / Department of Justice / HHS / United States Senate / Congress / Federal Government / office of Diversion Control / U.S. House of Representatives / national government / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Substance Abuse and Mental Health Services Administration / Rules and Regulations Office / Drug Enforcement Administration / Environmental Protection Agency / /

Person

DEA STRIDE / H. Westley Clark / Final Rule / Lois Rossi / Robert Lubran / /

/

Position

Benefits The Secretary / Comptroller General of the United States / Notices Executive / physician / Director / Registration Division / Secretary / OTP program physician / Director database and cross / Governor / Director / Executive / OTP physician / Nurse / Major / office-based physician / OTP Medical Director / Director / Registration Division / /

Product

Subutex / Regulations Term Opioid / naloxone / Suboxone / ORLAAM / Fentanyl / Adverse Action Regarding / Oxycontin / V narcotic / Federal Food / Subutex® / /

PublishedMedium

The American Journal / /

RadioStation

Katz / /

Region

Northeast U.S. / /

Technology

issued two treatment improvement protocols / food processors / /

URL

www.dpt.samhsa.gov / http /

SocialTag